Detalhe da pesquisa
1.
Blood pressure targets in chronic kidney disease: an update on the evidence.
Curr Opin Nephrol Hypertens
; 29(3): 327-332, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32167996
2.
A Self-management Approach for Dietary Sodium Restriction in Patients With CKD: A Randomized Controlled Trial.
Am J Kidney Dis
; 75(6): 847-856, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31955921
3.
Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis.
Nephrol Dial Transplant
; 31(9): 1494-501, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26602863
4.
Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
Am J Kidney Dis
; 65(2): 259-66, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25278093
5.
Vitamin D analogues to target residual proteinuria: potential impact on cardiorenal outcomes.
Nephrol Dial Transplant
; 30(12): 1988-94, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25609737
6.
Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease.
Curr Opin Nephrol Hypertens
; 23(6): 533-40, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25222815
7.
Effects of Potassium or Sodium Supplementation on Mineral Homeostasis: A Controlled Dietary Intervention Study.
J Clin Endocrinol Metab
; 105(9)2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32506135
8.
Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy.
Medicine (Baltimore)
; 95(46): e5003, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27861335
9.
Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation.
Clin J Am Soc Nephrol
; 8(11): 1968-78, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23929933